Provided to more than a quarter of cancer patients, today’s targeted radiotherapy has come a long way from its experimental, and Nobel Prize winning, origins. When administering the treatment, shaping ...

A new study now reports that there is an alternative to the conventional CyberKnife treatment delivery system. This new technique uses a multileaf collimator (MLC) and can flexibly sculpt a single ...

Accuray Incorporated ARAY recently announced the availability of its InCise Multileaf Collimator (MLC) for the CyberKnife M6 System in international markets, where it has already been approved for ...

Accuray Incorporated (Nasdaq: ARAY) and Lancaster General Health announced today that the first commercially available InCise™ Multileaf Collimator (MLC) for the CyberKnife ® M6™ System has been ...

The shape of things to come: LAP and OTH Amberg-Weiden are developing a next-generation drive and control unit that promises an order-of-magnitude improvement in the speed and precision of the MLC ...

Accuray Incorporated (Nasdaq: ARAY) announced today that the InCise™ Multileaf Collimator (MLC) for the CyberKnife ® M6™ System will now be available outside the United States in markets where it is ...

MRI-guided radiotherapy systems offer the ability to visualize tumour targets and surrounding organs with high accuracy, with the potential to perform real-time treatment adaptation based on ...

Agility MLC and other Elekta solutions at American Association of Physicists in Medicine (AAPM) Annual Meeting to demonstrate how integration streamlines clinical workflow Agility is Elekta's latest ...

Elekta, a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders, has received clearance to CE mark Agility, a revolutionary beam-shaping ...

Renowned radiosurgery systems maker, Accuray Incorporated (ARAY) recently received the U.S. Food and Drug Administration (“FDA”) 510(k) approval for its new Cybernife M6 Series. This innovative series ...